Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HX9428 in Wet Age-related Macular Degeneration
NCT07185841Phase 2Recruiting
- Sponsor
- Haixi New Pharma
- Start
- Jul 2025
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HX9428 in exudative macular degeneration, sponsored by Haixi New Pharma. Started Jul 2025; status: recruiting.
02
Drugs
HX9428
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on NCT07185841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07185841.